Delnova Announces First-In-Human Demonstration Of Reversal Of Neurotoxin Muscle Weakness
DelNova Inc., is developing a rescue drug, ReViVox®, to resolve side effects that may result from botulinum neurotoxin treatment. Neurotoxins, such as Botox®, Dysport®, Xeomin®, Jeauveau® and, most recently, Daxxify®, are used for wrinkle reduction in facial aesthetics. Although neurotoxins are effective in reducing wrinkle severity…
Read More
0
